DKK3 and adrenal cortex carcinoma: Twelve of 18 ACC samples with hyper- or intermediate promoter methylation (67%) also showed significant reduction in DKK3 expression, concurring with the established role of promoter methylation in DKK3 silencing in other tumors [36, 37].